PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
Abstract Abnormal angiogenesis occurs during the growth of solid tumors resulting in increased vascular permeability to fluids and metastatic cancer cells. Anti-angiogenesis therapy for solid tumors is effective in the treatment of cancer patients. However, the efficacy of anti-angiogenesis therapy...
Main Authors: | Xin Zhang, Kexin Wang, Xingbo Feng, Jian Wang, Yali Chu, Chunmeng Jia, Qingsi He, Cheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-11-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04352-w |
Similar Items
-
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
by: Hao Liu, et al.
Published: (2024-02-01) -
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
by: Zhongwei Li, et al.
Published: (2021-11-01) -
OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
by: Yue Liu, et al.
Published: (2022-04-01) -
PRMT3 methylates HIF-1α to enhance the vascular calcification induced by chronic kidney disease
by: Guangyu Zhou, et al.
Published: (2024-01-01) -
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
by: Xiao Jin, et al.
Published: (2020-06-01)